This prospective, randomized, placebocontrolled study evaluated the effects of dexketoprofen as an adjunct to lidocaine in intravenous regional anaesthesia (IVRA) or as a supplemental intravenous (i.v.) analgesic. Patients scheduled for elective hand or forearm soft-tissue surgery were randomly divided into three groups. All 45 patients received 0.5% lidocaine as IVRA. Dexketoprofen was given either i.v. or added into the IVRA solution and the control group received an equal volume of saline both i.v. and as part of the IVRA. The times of sensory and motor block onset, recovery time and postoperative analgesic consumption were recorded. Compared with controls, the addition of dexketoprofen to the IVRA solution resulted in more rapid onset of sensory and motor block, longer recovery time, decreased intra-and postoperative pain scores and decreased paracetamol use. It is concluded that coadministration of dexketoprofen with lidocaine in IVRA improves anaesthetic block and decreases postoperative analgesic requirements.
Introduction
Intravenous regional anaesthesia (IVRA) is an effective anaesthetic method for surgery on the upper and lower extremities. 1 -4 Due to frequent tourniquet pain and the lack of postoperative analgesic effect, 2,3 the use of IVRA is limited to minor surgeries of short duration. The use of paracetamol or nonsteroidal anti-inflammatory drugs (NSAIDs), such as ketorolac or lornoxicam, in combination with lidocaine, improves the postoperative analgesic effect of IVRA. 1 -8 Dexketoprofen trometamol is an NSAID These data were partially presented at the Turkish Anaesthesia and Reanimation Congress 27 -30 October 2010, abstract P407. These data were also accepted for presentation at The European Society of Regional Anaesthesia Congress, Dresden, Germany, 7 -10 September 2011. S Yurtlu, V Hanci, E Kargi et al. Dexketoprofen for intravenous regional anaesthesia that has recently been introduced in parenteral form. 9, 10 It has yet to be fully evaluated as an adjunct for IVRA. It is hypothesized that coadministration of dexketoprofen and lidocaine will improve postoperative analgesia in IVRA. The present study compared the postoperative analgesic effect of IVRA with or without dexketoprofen with intravenous (i.v.) dexketoprofen.
Patients and methods PATIENTS
Patients scheduled for elective hand or forearm soft tissue surgery at the School of Medicine, Zonguldak Karaelmas University, Zonguldak, Turkey, between February 2009 and May 2010 were enrolled in this prospective, randomized, double-blind study. Patients were aged 18 -65 years and had an American Society of Anesthesiologists' (ASA) physical classification status of I or II. 11 Exclusion criteria were: (i) analgesic drug treatment in the previous 24 h; (ii) history of allergy to study medications; (iii) any neurological deficit in the upper extremities; and (iv) the presence of any contraindications to IVRA.
The Ethics Committee of Karaelmas University Hospitals, Zonguldak, Turkey approved the study and all patients had to provide verbal informed consent to participate in the study.
ANAESTHETIC PROCEDURES
The numerical pain rating scale (NRS: 0, no pain; 10, the worst pain imaginable) was explained to all patients at their preoperative visit. All patients were premedicated with midazolam 0.07 mg/kg intramuscularly (i.m.) 30 min before surgery. Standard monitoring (mean arterial blood pressure [MAP], peripheral oxygen saturation [SpO 2 ] and heart rate [HR]) was applied, and i.v. cannulae for crystalloid infusion were placed in the dorsum of each hand.
Complete venous drainage was achieved by wrapping an elastic bandage around the arm and a double-cuffed, pneumatic tourniquet was applied on the upper part of the arm and inflated to 250 mmHg. Circulatory isolation of the arm was confirmed by the absence of radial pulse and loss of pulse oximetry signal.
Patients were randomized into the three treatment groups using random sample tables. All drugs were prepared in identical syringes by an anaesthetist who was blinded to the study conditions. In all cases, IVRA was achieved with 3 mg/kg of 2% lidocaine (Aritmal ® ; Biosel, Istanbul, Turkey) diluted to 40 ml with saline (final concentration 0.5% lidocaine). Patients in the IVRA group also received 2 ml dexketoprofen 50 mg (Arveles ® ; Ibrahim Ethem Ilac San., Istanbul, Turkey) in their IVRA solution. Patients in the i.v. and control groups received 2 ml saline in their IVRA solutions. Patients in the i.v. group received dexketoprofen 50 mg i.v. in 2 ml saline in their non-operative hand 10 min before tourniquet inflation, and patients in the control and IVRA groups received a 2ml 0.9% saline control injection in their nonoperative hand. Anaesthetists (S.Y., V.H., B.G.K., R.D.O.) who were blinded to the study conditions administered all drugs, evaluated the anaesthetic block and recorded the data.
STUDY ASSESSMENTS
The sensory block in the dermatomal supply area of five nerves (ulnar, median, radial, medial and lateral antebrachial cutaneous) was assessed by pinprick test at 1-min intervals until 10 min after tourniquet inflation. The time of onset of the sensory block was defined as the time between drug injection and the development of complete sensory block. Motor block was assessed by extension and flexion of wrist and fingers at S Yurtlu, V Hanci, E Kargi et al. Dexketoprofen for intravenous regional anaesthesia 1-min intervals, and the time of onset of the motor was defined as the time between drug injection and the development of complete motor block.
After completion of the evaluations (10 min after tourniquet inflation), the distal tourniquet was inflated before deflation of the proximal tourniquet and surgery was allowed to begin. MAP, HR, SpO 2 and NRS scores were recorded at baseline and 10, 20 and 30 min after distal tourniquet inflation. If the NRS was > 3 at any time, 1 µg/kg fentanyl (fentanyl citrate; Abbott, Abbott Park, IL, USA) was administered and total fentanyl consumption was recorded. After surgery, the tourniquet was deflated if at least 30 min had passed after inflation. Sensory block recovery time (time from tourniquet deflation to return of pain assessed by pinprick test) and motor block recovery time (time from tourniquet deflation to restoration of finger movement) were determined. An anaesthetist who was blinded to the study conditions measured and recorded the haemodynamic data and NRS scores just after tourniquet release and 30 min, 2 and 4 h after surgery When postoperative NRS was > 3, 75 mg diclofenac i.m. was administered. The time from diclofenac injection to patient request for analgesic was recorded as time to first analgesic request. If the NRS score was > 3 within the first 24 h after surgery, patients were free to receive paracetamol 500 mg orally (maximum 8 doses/24 h) as rescue analgesia. Total 24-h paracetamol dose was recorded.
Side-effects, including skin rash, gastric discomfort, tinnitus and nausea and vomiting, that occurred within the first 24 h postoperatively, were noted.
STATISTICAL ANALYSES

Sample size estimation was performed using
Power Calculator (Department of Statistics, University of California, Los Angeles, CA, USA) and was based on a previous study where postoperative paracetamol requirement for patients receiving lidocaine IVRA was 1400 ± 207 mg. 4 Based on calculations using the SD of the earlier study, 4 with an error of 0.05 and a power of 90%, it was estimated that a sample size of 14 patients was required per group to detect a 15% change in analgesic consumption. Thus, 15 patients were included in each study group.
Statistical analyses were performed using the SPSS ® statistical package, version 11.5 (SPSS Inc., Chicago, IL, USA) for Windows ® . The primary endpoint was postoperative analgesic consumption. Analysis of distribution was performed by the Kolmogorov-Smirnov test. The Kruskal-Wallis test and Mann-Whitney U-test were used to analyse the following: demographic data; haemodynamic data; onset and recovery times of sensory and motor blocks; duration of surgery, tourniquet inflation and analgesia; intraoperative and postoperative NRS scores; and analgesic use. Side-effects and type of surgery were compared with Fisher's exact test. A P-value < 0.05 was considered to be statistically significant.
Results
The study recruited 45 patients, 15 in each group, who were scheduled for elective hand or forearm soft tissue surgery, all of whom completed the study. There were no statistically significant between-group differences in terms of age, weight, gender distribution, ASA status, duration of tourniquet inflation and duration or type of surgery (Table 1 ). There were no statistically significant between-group differences in haemodynamic data at any time ( Table 2) . None of the patients felt pain with incision.
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Patients in the IVRA group had significantly shorter onset times for both sensory and motor block and longer recovery times compared with the i.v. and control groups (P < 0.05; Table 3 ). The number of patients requiring fentanyl for intraoperative pain was significantly lower in the i.v. and IVRA groups compared with controls (P < 0.05; Table 4 ). Total intraoperative fentanyl requirement was significantly higher in controls compared with patients in the IVRA and i.v. groups (P < 0.05 for both; Table 4 ). The time to first postoperative analgesic request was significantly shorter and the 24h paracetamol consumption was significantly higher in control patients than in the IVRA or i.v. groups (P < 0.05; Table 4 ).
The NRS scores at the intraoperative 20-and 30-min and the postoperative 30-min, 2and 4-h timepoints were significantly lower in the IVRA group than in the control group (P < 0.05; Table 5 ). Patients in the i.v. group reported significantly lower NRS scores at 30 min, 2 h and 4 h postoperatively compared with controls (P < 0.05; Table 5 ). A skin rash developed within a few minutes of the injection of anaesthetic solution in one patient in the IVRA group. The rash was limited to the forearm distal to the tourniquet; the patient had a history of asthma. This patient did not develop any systemic sideeffects. None of the patients had excessive intraoperative bleeding, postoperative gastric discomfort or vomiting. Nausea was present in one patient in the i.v. group, tinnitus was observed in one patient each in the i.v. and Data presented as mean ± SD, or number (%). There were no statistically significant between-group differences (P > 0.05); Kruskal-Wallis test was used for continous data, and Fisher's exact test was used for categorical data. a 40 ml 0.5% lidocaine + 2 ml saline IVRA + 2 ml dexketoprofen 50 mg i.v.; b 40 ml 0.5% lidocaine + 2 ml saline IVRA + 2 ml 0.9% saline i.v.; c 40 ml 0.5% lidocaine + 2 ml dexketoprofen 50 mg IVRA + 2 ml 0.9% saline i.v. ASA, American Society of Anesthesiologists physical classification status.
Control
TABLE 1:
Demographic data, type and duration of surgery, and duration of tourniquet inflation for patients undergoing elective hand or forearm soft-tissue surgery who received intravenous regional anaesthesia with dexketoprofen (IVRA), intravenous regional anaesthesia with separate intravenous dexketoprofen (i.v.), or control S Yurtlu, V Hanci, E Kargi et al. Dexketoprofen for intravenous regional anaesthesia IVRA groups, and two patients in the IVRA group complained of dizziness. There were no significant between-group differences in the incidence of any side-effect.
Discussion
Dexketoprofen is a potent inhibitor of prostaglandin synthesis in vitro 12 and demonstrates good analgesic activity compared with other NSAIDs. 13, 14 In a rat model, the combination of dexketoprofen with fentanyl led to a five-fold increase in the antinociceptive effect of fentanyl and induced a more powerful and longer-lasting Data presented as mean ± SD. There were no statistically significant between-group differences (P > 0.05); Kruskal-Wallis test. a 40 ml 0.5% lidocaine + 2 ml saline IVRA + 2 ml dexketoprofen 50 mg i.v.; b 40 ml 0.5% lidocaine + 2 ml saline IVRA + 2 ml 0.9% saline i.v.; c 40 ml 0.5% lidocaine + 2 ml dexketoprofen 50 mg IVRA + 2 ml 0.9% saline i.v. Onset and recovery times of sensory and motor blocks for patients undergoing elective hand or forearm soft-tissue surgery who received intravenous regional anaesthesia with dexketoprofen (IVRA), intravenous regional anaesthesia with separate intravenous dexketoprofen (i.v.), or control S Yurtlu, V Hanci, E Kargi et al. Dexketoprofen for intravenous regional anaesthesia analgesic effect than fentanyl alone. 15 The present study demonstrated that the use of dexketoprofen as an adjunct to lidocaine for IVRA decreased intraoperative pain, postoperative analgesic use, fentanyl consumption and the onset times of sensory and motor block.
Previous studies have demonstrated several NSAIDs, including tenoxicam, 16 3, 5, 7 to be effective adjuncts for IVRA, reducing tourniquet pain and prolonging postoperative anaesthesia. 2 -7 The mechanism of action of NSAIDs is commonly believed to be via inhibition of the cyclo-oxygenase (COX)-2 enzyme and a subsequent decrease in prostaglandin levels 22 that are normally upregulated by surgical trauma. 2, 22, 23 An alternative mechanism is NSAID-mediated activation of the nitric oxide-cyclic guanosine monophosphate pathway, resulting in an antinociceptive effect. 24 Dexketoprofen is a non-selective COX inhibitor, and a concentrated dose at the surgical site may provide fast and efficient inhibition of COX-2 leading to decreased levels of local prostaglandins. 22 -30 Similar mechanisms of action have been proposed for previously studied NSAID adjuvants for IVRA. 2 -5,7,17 In terms of decreased intraoperative pain, the present findings were similar to previous studies of NSAID adjuncts for IVRA. 2 -5,7,17 The times to onset of sensory and motor block in the present study were shortened and recovery times were extended when dexketoprofen was used as an adjunct for IVRA. The pharmacological formulation of the dexketoprofen used included 100 mg/ml ethanol as an excipient. 31, 32 Ethanol has been used for neurolytic blockade in pain therapy for several decades, 33, 34 and it is possible that it contributed to the faster development of sensory and motor block and longer recovery times in the IVRA group in the present study. An increase in the recovery time of the sensory block is advantageous in cases where the tourniquet is deflated before skin closure in order to control bleeding.
There were no serious side-effects observed with dexketoprofen treatment in the present study. A previous multicentre study determined that the risk of gastrointestinal bleeding increased with dexketoprofen dose > 50 mg/day. 35 Thus, the dose of dexketoprofen used in the present study was limited to 50 mg and, as 50 mg was found to be effective, we suggest that higher doses of dexketoprofen should be avoided. The small sample size of the present study limits the usefulness of the side-effects data, as bleeding, gastrointestinal side-effects or local/systemic drug reactions may be seen in larger study populations.
In conclusion, the present study found that the addition of dexketoprofen 50 mg to lidocaine for IVRA improved postoperative analgesia and decreased the need for supplementary intraoperative analgesia. The optimal dose of dexketoprofen remains to be determined.
